However, the lack of baseline thrombosis history assessment limits our ability to discern causality, and the association with baseline erythrocytosis is confounded by insufficient investigation into its causes—such as EPO levels or JAK2 mutation status—as only 1.6% of erythrocytosis patients received hematology consultations, potentially missing underlying conditions like PV. The gene discussed is JAK2; the disease is polycythemia.